COMMUNIQUÉS West-GlobeNewswire

CareDx to Announce Fourth Quarter 2018 Financial Results on March 6th, 2019
14/02/2019
BRISBANE, Calif., Feb. 14, 2019 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a molecular diagnostics company focused on the discovery, development and commercialization of clinically differentiated, high-value [...]
TYME Reports Encouraging SM-88 Clinical Results without Typical Hormone-Related Side Effects in Phase II Study of Patients with Biomarker Recurrent Prostate Cancer
14/02/2019
SM-88 therapy did not exhibit typical side effects associated with hormonal castration from androgen-deprivation therapy (ADT) 87% of patients (20/23) remained free of radiographic progression After 12 weeks, all [...]
FluroTech's CompleTest™ Makes Cannabis Testing More Accessible -- CFN Media
14/02/2019
SEATTLE, Feb. 14, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an [...]
BioTime Provides Business Update Including Information on AgeX, OncoCyte and Asterias
14/02/2019
ALAMEDA, Calif., Feb. 14, 2019 (GLOBE NEWSWIRE) -- BioTime, Inc. (NYSE American: BTX), a clinical-stage biotechnology company focused on degenerative diseases, today provided a business update which included information [...]
Outlook Therapeutics Provides Business Update and Reports First Quarter Financial Results for Fiscal 2019
14/02/2019
CRANBURY, N.J., Feb. 14, 2019 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (NASDAQ:OTLK) (the “Company”) today reported financial results and business highlights for its first fiscal quarter ended December 31, 2018. [...]
Blueberries Medical Corp Enters into Letter of Intent With El Manantial Medical Centers for Rapid Product Commercialization & Patient Acquisition; To Build Two Pharmacies to Support JV
14/02/2019
TORONTO, Feb. 14, 2019 (GLOBE NEWSWIRE) -- Blueberries Medical Corp. (CSE: BBM) (the “ Company ” or " Blueberries "), a leading Colombia-based licenced producer of medicinal cannabis and cannabis-derived products, has [...]
Translate Bio to Present at the 8th Annual SVB Leerink Partners Global Healthcare Conference
14/02/2019
LEXINGTON, Mass., Feb. 14, 2019 (GLOBE NEWSWIRE) -- Translate Bio (Nasdaq: TBIO), a clinical-stage messenger RNA (mRNA) therapeutics company developing a new class of potentially transformative medicines to treat [...]
Drinkworks™ Doubles Down on Recycling Solutions with Loop Industries, Inc.
14/02/2019
Partnership with Loop Industries will Provide a Free Mail-back Program for Cocktail, Cider and Beer Enthusiasts Seeking to Ensure Drinkworks Products are Upcycled BEDFORD, Mass. and MONTREAL, Feb. 14, 2019 (GLOBE [...]
RTI Surgical® Schedules Fourth Quarter and Full Year 2018 Earnings Call for February 28, 2019
14/02/2019
ALACHUA, Fla., Feb. 14, 2019 (GLOBE NEWSWIRE) -- RTI Surgical, Inc. (Nasdaq: RTIX), a global surgical implant company, today announced it plans to release financial results from the fourth quarter and full year 2018 on [...]
Athenex, Inc. to Report Fourth Quarter and Fiscal Year 2018 Earnings Results on March 11, 2019
14/02/2019
BUFFALO, N.Y., Feb. 14, 2019 (GLOBE NEWSWIRE) -- Athenex, Inc. (Nasdaq: ATNX), a global biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies for the treatment of [...]
Recro Pharma to Report Fourth Quarter and Year End 2018 Financial Results and Host Conference Call and Webcast on February 19, 2019
14/02/2019
Conference Call and Webcast Scheduled for Tuesday, February 19, 2019 at 8:00 a.m. ET MALVERN, Pa., Feb. 14, 2019 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (NASDAQ:REPH), a revenue generating specialty pharmaceutical [...]
EyePoint Pharmaceuticals Announces Fiscal Period Ended December 31, 2018 Financial Results Release Date and Conference Call Information
14/02/2019
WATERTOWN, Mass., Feb. 14, 2019 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT), a specialty biopharmaceutical company committed to developing and commercializing innovative ophthalmic products, will [...]
Evelo Biosciences Reports Fourth Quarter and Full Year 2018 Financial Results and Business Highlights
14/02/2019
-- First Patient Dosed in University of Chicago Phase 2a Trial of EDP1503 in Metastatic Melanoma -- -- Preclinical Studies Have Shown Non-replicating Monoclonal Microbials Maintain Activity: EDP1867 in Development [...]
Axogen, Inc. to Report Fourth Quarter and Full Year 2018 Financial Results and Host Conference Call on February 26, 2019
14/02/2019
ALACHUA, Fla., Feb. 14, 2019 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for damage or discontinuity to peripheral nerves, today announced [...]
Agios Reports Fourth Quarter and Full Year 2018 Financial Results
14/02/2019
– Strong Launch of TIBSOVO ® Continues with Net Revenue of $9.4M for the Fourth Quarter and $13.8M for Full Year 2018 – – Phase 3 ClarIDHy Trial of TIBSOVO ® in Second Line or Later Cholangiocarcinoma Fully Enrolled [...]
Aravive Expands Executive Team with Promotion of Gail McIntyre, PhD, DABT to Chief Scientific Officer
14/02/2019
HOUSTON, Feb. 14, 2019 (GLOBE NEWSWIRE) -- Aravive, Inc. (Nasdaq: ARAV), a clinical-stage biopharmaceutical company, announced that the company has promoted Gail McIntyre, PhD, DABT to chief scientific officer. “Aravive [...]
Breathtec Announces Name Change to Algernon Pharmaceuticals
14/02/2019
New corporate identity aligned with the Company's main strategy to be a global leader in the treatment of liver disease (NASH), chronic kidney disease and inflammatory bowel disease. The company's ticker symbol will [...]
Canada House Wellness Group Inc. Accelerates Phenotyping of 62 In-House Genetics
14/02/2019
TORONTO, Feb. 14, 2019 (GLOBE NEWSWIRE) -- Canada House Wellness Group Inc. (“Canada House” or the “Company”) (CSE:CHV) and Abba Medix Corp. (“Abba”), CHV’s wholly owned Licensed Producer has accelerated their [...]
Axovant Announces Formation of Arvelle Therapeutics and Strategic Transition of Legacy Small Molecule Team Into Newly Formed Company
14/02/2019
Transition of small molecule expertise to Arvelle completes transformation of Axovant into a company focused exclusively on gene therapies Axovant will receive a preferred equity stake in Arvelle, which has received [...]

Pages